Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)
Price and Volume
Detailed Quote| Volume | 24,517,586 |
| Open | 2.860 |
| Bid (Size) | 2.800 (50,300) |
| Ask (Size) | 2.810 (14,200) |
| Prev. Close | 2.830 |
| Today's Range | 2.770 - 2.960 |
| 52wk Range | 2.500 - 5.240 |
| Shares Outstanding | 168,425,907 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
52-Week Range
46.4% below 52-week high
2.810
2.5052W Low
5.2452W High
1 Week
18.8% below 1-week high
2.501W Low
3.461W High
Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) traded between $2.50 and $5.24 over the past 52 weeks and last traded at $2.81, 46.4% below its 52-week high. Over the past week it ranged between $2.50 and $3.46.
Past 12 Months
1W
-$0.52
1M
-$0.80
3M
-$0.69
6M
-$0.15
YTD
-$1.39
1Y
-$1.35
RXRX was -32.5% over the past year, -5.1% over six months, -33.1% year to date, -15.6% in the last week.
12 Months vs Market
RXRX
-32.5%
DIA
+7.1%
SPY
+9.3%
QQQ
+9.2%
IWM
+14.1%
Over the past 12 months RXRX returned -32.5% versus DIA (Dow) +7.1%, SPY (S&P 500) +9.3%, QQQ (Nasdaq 100) +9.2% and IWM (Russell 2000) +14.1%.
Volume & Liquidity
1.02× 3-mo avg
Today 24,517,586
3-mo avg 23.9M
1W
27.8M
1M
22.5M
3M
23.9M
6M
22.3M
YTD
19.8M
1Y
20.2M
RXRX most recently traded 24,517,586 shares against a 3-month average daily volume of 23.9M.
More News
Read More
Recursion to Participate in Upcoming Investor Conferences
November 11, 2026
Recursion (RXRX) Q3 2026 Earnings Call Transcript ↗
November 03, 2026
What Recursion Pharmaceuticals (RXRX) Said on Its Q3 Earnings Call ↗
November 03, 2026
Recursion Appoints Fred Hassan as Chair of the Board
November 02, 2026
1 Big Winner and 1 Loser From the Upcoming Anthropic IPO ↗
October 31, 2026
Next-Gen Biotech: RXRX, OCGN, SNTI, VIVS, ONCO Stocks to Watch
October 28, 2026
2 Beaten-Down Stocks to Avoid Right Now ↗
September 08, 2026
The Market Just Told You Which Layer Of AI Biology It Is Paying For
September 03, 2026
Recursion (RXRX) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Recursion Pharmaceuticals Q2 Earnings Call Highlights ↗
August 05, 2026
Frequently Asked Questions
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 2.810
When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 11/19/26 01:34 PM ET
What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 473.28M
How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Recursion Pharmaceuticals, Inc. - Class A Common Stock has 473M shares outstanding.